Skip to content
Open in App
Amanat Acquisition logo

Amanat Acquisition

web2

Amanat Acquisition is a publicly traded special purpose acquisition company formed to combine w...

Symbol ยท AMAN
Company profile

About

Amanat Acquisition is a publicly traded special purpose acquisition company formed to combine with another business, with an investment focus on healthcare and life sciences. The company raised capital through a public offering and trades on Nasdaq under the symbol AMAN. In October 2026, it announced a definitive agreement to combine with Corxel Pharmaceuticals, a clinical stage developer of oral treatments for obesity and related conditions. The proposed transaction would bring Corxel's specified American business and development assets into a publicly listed company. Completion remains subject to shareholder approvals, regulatory requirements and other closing conditions. Amanat does not itself operate Corxel's pharmaceutical development business.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeNasdaqPrimary symbol: AMAN
Expert coverage

Amanat Acquisition profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment